Switzerland: After Being Ignored by The Courts, Lawyer Goes Public with Criminal Case Against Swissmedic and Demands Immediate Suspension of Vaccines
On 14 November, a Zurich attorney announced a lawsuit against three officials in Swissmedic and five in Insel Group, which runs a large hospital centre in Bern.
The complaint alleges Swissmedic violated the nationâs criminal code by approving poorly tested, ineffective vaccines and then ignoring thousands of Swiss cases of related disability and death. Insel Group is part, it states, of the âcircle of offenders.â
Among many alleged injuries listed in the complaint, including disability and deaths, was this: âCollapse in birth rates: over 6,000 missing babies in 2022.â
On 14 July 2022, a lawyer filed a 300-page criminal complaint with the relevant cantonal prosecutor on behalf of six people allegedly injured by mRNA vaccinations. It is aimed at three representatives of the Swiss regulatory and supervisory authority for pharmaceuticals and medical devices (âSwissmedicâ) and five vaccinating doctors from the Bern Inselspital. The lawyer, Philipp Kruse, has now gone public with a media conference.
Further reading:
That is what the criminal complaint against Swissmedic is about, SRF, 14 November 2022
Covid: Victims file a criminal complaint against Swissmedic and doctors, Medinside, 14 November 2022
By going public, the plaintiffs want to prevent more people from being harmed by the novel and harmful mRNA vaccines, Kruse said.
The criminal complaint comprises around 300 pages and can be viewed HERE together with the scientific evidence â evidence report, around 300 pages, plus 1,200 pieces of evidence.
A criminal case has been opened for one of the plaintiffs against vaccinating doctors. But regarding the main proceedings, the Public Prosecutorâs Office, four months after charges were filed, has not even informed the team who is responsible or whether proceedings have started. As the authorities have remained largely passive since the criminal complaint was filed, on 14 November, lawyers representing the plaintiffs held a press conference to present the facts and the results of their comprehensive year-long investigation.
Making presentations at the press conference were Dr. Michael Palmer, Professor Andreas SĂśnnichsen, Professor Martin Haditsch, Professor Konstantin Beck and Dr. Urs Guthauser, along with former senior public prosecutor Jurg Vollenweider and former deputy public prosecutor Markus Zollinger.
The presentations show that Swissmedic has seriously and permanently violated their duty of care in relation to medicinal products, with serious consequences for young, healthy people and the entire population.
The press conference is in German. You can watch it HERE. By selecting the âtranscriptâ option on YouTube a window showing the English translation can be read. For some reason, the English transcript is ahead of the speakers. However, within the transcript are numbers beginning and ending with â#â denoting where the transcript begins in the video. So, for non-German speakers, it will be easier to read the transcript. You can download a copy of the slides used in the presentations HERE, labelled as âPowerPoint,â for the English version select âIN.â
According to the Therapeutic Products Act, Swissmedic is obliged to take all measures to ensure that peopleâs health is not endangered. This includes recording risks regularly, systematically and with foresight. Additionally, the Act requires Swissmedic to ensure that no products are released whose quality, safety and effectiveness have not been proven. If the responsible persons at Swissmedic breach these elementary duties of care, they are liable to prosecution.
The legal team noted that:
Contrary to the public announcements by Swissmedic, the mandatory legal requirements regarding the quality, effectiveness and safety of the mRNA âvaccinesâ were never met. The manufacturersâ approval studies do not show that the vaccines are effective in reducing transmission, nor that they can prevent serious illnesses or deaths.
Solid studies that have proven the safety of the new vaccine in pregnant women are still missing. Studies that supposedly prove the safety of this vulnerable group are methodologically insufficient. Even within Swissmedic, the Human Medicines Expert Committee explicitly warned of possible risks during pregnancy. The vaccination recommendation for pregnant women is still based on hypotheses and insufficient data.
Swissmedic has failed to subject the products that were hastily approved in violation of the minimum legal standards to a consistent and risk-adequate, active product surveillance (so-called pharmacovigilance).
https://expose-news.com/2022/12/01/lawyer-goes-public-with-criminal-case/